Sort   by:  
 Page size 
UnknownAdvances in Risk Classification and Treatment Strategies for Neuroblastoma.
Not available
S-EPMC4567703 | biostudies-literature
UnknownPhase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial.
Not available
S-EPMC4872349 | biostudies-literature
UnknownOutcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
Not available
S-EPMC3383182 | biostudies-literature
UnknownClinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.
Not available
S-EPMC3675667 | biostudies-literature
Sort   by:  
 Page size